Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CLDX

Celldex

$0.28

0.011 (4.17%)

16:05
12/10/18
12/10
16:05
12/10/18
16:05
Hot Stocks
Celldex announces resignation of board chairman Gerald McMahon »

On December 5, 2018,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
CLDX

Celldex

$0.31

-0.0002 (-0.06%)

14:32
11/20/18
11/20
14:32
11/20/18
14:32
Hot Stocks
Celldex announces launch of Chase Offers »

Cardlytics announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLDX

Celldex

$0.36

-0.0169 (-4.45%)

13:04
11/11/18
11/11
13:04
11/11/18
13:04
Hot Stocks
Celldex presents emerging MerTK antibody program »

Celldex Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
CLDX

Celldex

$0.38

0.0435 (12.93%)

08:33
11/09/18
11/09
08:33
11/09/18
08:33
Hot Stocks
Celldex presents interim data from CDX-1140 at SITC »

Celldex presented interim…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
CLDX

Celldex

$0.46

0.0063 (1.39%)

16:12
08/08/18
08/08
16:12
08/08/18
16:12
Earnings
Celldex reports Q2 EPS (11c), consensus (14c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

CLDX

Celldex

$0.58

-0.0029 (-0.49%)

, BMY

Bristol-Myers

$53.13

0.51 (0.97%)

15:44
06/03/18
06/03
15:44
06/03/18
15:44
Hot Stocks
Celldex presents data from Phase 1/2 study of Varlilumab, Opdivo »

Celldex Therapeutics…

CLDX

Celldex

$0.58

-0.0029 (-0.49%)

BMY

Bristol-Myers

$53.13

0.51 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

  • 05

    Jun

  • 05

    Jun

  • 10

    Jul

CLDX

Celldex

$0.78

0.029 (3.87%)

08:15
05/10/18
05/10
08:15
05/10/18
08:15
Earnings
Celldex reports Q1 EPS (84c), consensus (20c) »

Reports Q1 revenue $4.1M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLDX

Celldex

$0.76

-1.395 (-64.73%)

07:13
04/17/18
04/17
07:13
04/17/18
07:13
Downgrade
Celldex rating change at Cantor Fitzgerald »

Celldex downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLDX

Celldex

$0.76

-1.395 (-64.73%)

05:53
04/17/18
04/17
05:53
04/17/18
05:53
Downgrade
Celldex rating change at Cantor Fitzgerald »

Celldex downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLDX

Celldex

$2.15

-0.09 (-4.02%)

13:02
04/16/18
04/16
13:02
04/16/18
13:02
Downgrade
Celldex rating change at Cowen »

Celldex downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.